Brian Donnelly
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brian Donnelly
Myriad Genetics Inc reported in an 8-K filed October 9, 2026 that Brian Donnelly resigned as Chief Commercial Officer, effective September 21, 2026. Brian Donnelly has spoken on 1 earnings call across 1 company, most recently for Myriad Genetics Inc on May 5, 2026.
“By signing this Agreement, Executive hereby confirms Executive's resignation, effective as of the Separation Date, from all positions Executive may hold as a director, officer or employee of Company and/or any of its subsidiaries or affiliates including, without limitation, the position of Chief Commercial Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Myriad Genetics Inc (MYGN)
Proxy statement
Start not stated–2026-09-21
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.